SCALANCE XRM334 (24V DC, 2x10G, 24xSFP, 8xSFP+) (6GK5334-5TS01-2AR3)

productUS

A product tracked in the threat graph; the vulnerabilities below are known to affect it.

by severity
1critical2high13medium0low
updated 2026-10-27
01

vulnerabilities (38)

Related CVEs.

IDseverity exploitable
CVE-2025-32433US—OT criticalKEV
CVE-2024-3596UScritical9.0OT highExploit
CVE-2025-4517US—Exploit
CVE-2025-4138US—Exploit
CVE-2024-7264USmedium6.5—
CVE-2024-6197UShigh7.5—
CVE-2024-9681USmedium6.5—
CVE-2024-11053US——
CVE-2025-0725US——
CVE-2024-52533US——
CVE-2025-0665US——
CVE-2025-4330US——
CVE-2024-8096US——
CVE-2024-6874USmedium4.3—
CVE-2024-12718US——
CVE-2023-39810UShigh7.8—
CVE-2025-0167US——
CVE-2025-3360US——
CVE-2025-4435US——
CVE-2025-10148US——
CVE-2025-40568US—OT elevated—
CVE-2025-27587US——
CVE-2025-40567US—OT elevated—
CVE-2023-42364USmedium5.5—
CVE-2023-42363USmedium5.5—
CVE-2023-42366USmedium5.5—
CVE-2023-42365USmedium5.5—
CVE-2024-41797US——
CVE-2024-47619US——
CVE-2025-40569US——
CVE-2024-8006USmedium4.4—
CVE-2023-7256USmedium4.4—
CVE-2025-4516US——
CVE-2025-38086USmedium5.5—
CVE-2025-38345USmedium5.5—
CVE-2025-38084USmedium5.5—
CVE-2025-1390US——
CVE-2025-38085USmedium4.7—
02

weaknesses (8)

The flaw types (CWEs) most of these CVEs share.

  • CWE-20Improper Input Validation7 CVEs
  • CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')6 CVEs
  • CWE-200Exposure of Sensitive Information to an Unauthorized Actor4 CVEs
  • CWE-416Use After Free4 CVEs
  • CWE-120Buffer Copy without Checking Size of Input ('Classic Buffer Overflow')2 CVEs
  • CWE-125Out-of-bounds Read2 CVEs
  • CWE-190Integer Overflow or Wraparound2 CVEs
  • CWE-295Improper Certificate Validation2 CVEs
03

sources (1)

Which sources assert this record, and when.

scry

Products carry known vulnerabilities once they are exposed to the internet. See what is exposed on your perimeter with a free passive scan.

Free scan